482 related articles for article (PubMed ID: 3128058)
1. Renal changes in patients with rheumatoid arthritis treated with sodium thiomalate and D-penicillamine.
Domljan Z; Borso G; Marinković M; Winter Fudurić I; Pucar I; Cikes N
Acta Med Iugosl; 1987; 41(5):363-72. PubMed ID: 3128058
[No Abstract] [Full Text] [Related]
2. Hematuria in patients with rheumatoid arthritis receiving gold and D-penicillamine.
Leonard PA; Bienz SR; Clegg DO; Ward JR
J Rheumatol; 1987 Feb; 14(1):55-9. PubMed ID: 3106632
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of rheumatoid arthritis with gold salts].
Aranguena L; Hinojosa W; Chincaro C; Portugal J; Barrenechea O
Rev Clin Esp; 1984 Jun 15-30; 173(5-6):305-8. PubMed ID: 6238373
[No Abstract] [Full Text] [Related]
4. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
[TBL] [Abstract][Full Text] [Related]
5. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
Wooley PH; Griffin J; Panayi GS; Batchelor JR; Welsh KI; Gibson TJ
N Engl J Med; 1980 Aug; 303(6):300-2. PubMed ID: 6770269
[TBL] [Abstract][Full Text] [Related]
6. Penicillamine in rheumatic diseases: a prospective study of tolerance and efficacy.
Munthe E; Kåss E
J Rheumatol Suppl; 1981; 7():107-11. PubMed ID: 6785435
[TBL] [Abstract][Full Text] [Related]
7. Gold vs D-penicillamine double blind study and followup.
Thomas MH; Rothermich NO; Philips VK; Bergen W; Hedrick SW
J Rheumatol; 1984 Dec; 11(6):764-7. PubMed ID: 6240537
[TBL] [Abstract][Full Text] [Related]
8. Precipitating autoantibody to a ubiquitous tissue antigen: association with rheumatoid arthritis treated with sodium aurothiomalate or d-penicillamine.
Palosuo T; Kajander A; von Essen R; Milgrom F
Clin Immunol Immunopathol; 1978 Jul; 10(3):355-64. PubMed ID: 97039
[No Abstract] [Full Text] [Related]
9. HLA-A,-B, and -DR antigens in relation to gold and D-penicillamine toxicity in Greek patients with RA.
Pachoula-Papasteriades C; Boki K; Varla-Leftherioti M; Kappos-Rigatou I; Fostiropoulos G; Economidou J
Dis Markers; 1986 Jun; 4(1-2):35-41. PubMed ID: 3133153
[TBL] [Abstract][Full Text] [Related]
10. HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.
Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb NJ
J Rheumatol; 1984 Oct; 11(5):610-4. PubMed ID: 6439866
[TBL] [Abstract][Full Text] [Related]
11. Is the mechanism of action during treatment of rheumatoid arthritis with penicillamine and gold thiomalate the same?
Jellum E; Aaseth J; Munthe E
Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):136-9. PubMed ID: 122761
[No Abstract] [Full Text] [Related]
12. Effects of long-term aurothiomalate and D-penicillamine treatments on renal function and urinary excretion of prostanoids in patients with rheumatoid arthritis.
Seppälä E; Lehtinen K; Isomäki H; Nissilä M; Harmoinen A; Mörsky P; Koivula T; Vapaatalo H
Int J Clin Pharmacol Res; 1988; 8(3):149-56. PubMed ID: 3136089
[TBL] [Abstract][Full Text] [Related]
13. Prior gold therapy does not influence the adverse effects of D-penicillamine in rheumatoid arthritis.
Kean WF; Lock CJ; Howard-Lock HE; Buchanan WW
Arthritis Rheum; 1982 Aug; 25(8):917-22. PubMed ID: 6214261
[TBL] [Abstract][Full Text] [Related]
14. [HLA antigens and side effects of gold and D-penicillamine in chronic polyarthritis].
Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb N
Wien Klin Wochenschr Suppl; 1984; 156():51-2. PubMed ID: 6442059
[No Abstract] [Full Text] [Related]
15. Adverse reactions to D-penicillamine after gold toxicity.
Dodd MJ; Griffiths ID; Thompson M
Br Med J; 1980 Jun; 280(6230):1498-500. PubMed ID: 6770953
[TBL] [Abstract][Full Text] [Related]
16. Penicillamine compared to previous chrysotherapy in rheumatoid arthritis.
Stein HB; Ruedy J; Atkins CJ; Offer RC
J Rheumatol; 1983 Apr; 10(2):319-22. PubMed ID: 6864688
[TBL] [Abstract][Full Text] [Related]
17. Proteinuria in D-penicillamine-treated rheumatoid arthritis.
Crawhall JC
J Rheumatol Suppl; 1981; 7():161-3. PubMed ID: 6939879
[TBL] [Abstract][Full Text] [Related]
18. Penicillamine nephropathy in rheumatoid arthritis. A clinical, pathological and immunological study.
Bacon PA; Tribe CR; Mackenzie JC; Verrier-Jones J; Cumming RH; Amer B
Q J Med; 1976 Oct; 45(180):661-84. PubMed ID: 1005658
[TBL] [Abstract][Full Text] [Related]
19. A method of comparing the toxicities of disease suppressive agents: possible application to a comparison between D-penicillamine and chloroquine.
Redda A; Anastassiades T
Clin Invest Med; 1984; 7(1):65-71. PubMed ID: 6426836
[TBL] [Abstract][Full Text] [Related]
20. [Comparative evaluation of the effectiveness of gold preparations and D-penicillamine and their tolerance in rheumatoid arthritis. I. The effect on the indicators of their activity and tolerance].
Slobodina GA; Kanevskaia MZ; Krel' AA; Chichasova NV
Revmatologiia (Mosk); 1989; (1):8-16. PubMed ID: 2501852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
